nodes	percent_of_prediction	percent_of_DWPC	metapath
Oseltamivir—ABCC4—Sorafenib—liver cancer	0.531	1	CbGbCtD
Oseltamivir—Oropharyngeal discomfort—Sorafenib—liver cancer	0.00652	0.0235	CcSEcCtD
Oseltamivir—Rhinorrhoea—Sorafenib—liver cancer	0.00585	0.0211	CcSEcCtD
Oseltamivir—Bone disorder—Sorafenib—liver cancer	0.00525	0.0189	CcSEcCtD
Oseltamivir—Influenza like illness—Sorafenib—liver cancer	0.00461	0.0166	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Sorafenib—liver cancer	0.00394	0.0142	CcSEcCtD
Oseltamivir—Hepatic failure—Sorafenib—liver cancer	0.00383	0.0138	CcSEcCtD
Oseltamivir—Eczema—Sorafenib—liver cancer	0.00383	0.0138	CcSEcCtD
Oseltamivir—Pain in extremity—Sorafenib—liver cancer	0.00344	0.0124	CcSEcCtD
Oseltamivir—Abdominal pain upper—Sorafenib—liver cancer	0.00314	0.0113	CcSEcCtD
Oseltamivir—Body temperature decreased—Epirubicin—liver cancer	0.00313	0.0113	CcSEcCtD
Oseltamivir—Hypothermia—Epirubicin—liver cancer	0.00313	0.0113	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Sorafenib—liver cancer	0.0031	0.0112	CcSEcCtD
Oseltamivir—Nasopharyngitis—Sorafenib—liver cancer	0.00308	0.0111	CcSEcCtD
Oseltamivir—Body temperature decreased—Doxorubicin—liver cancer	0.00289	0.0104	CcSEcCtD
Oseltamivir—Hypothermia—Doxorubicin—liver cancer	0.00289	0.0104	CcSEcCtD
Oseltamivir—Pneumonia—Sorafenib—liver cancer	0.00267	0.00961	CcSEcCtD
Oseltamivir—Infestation—Sorafenib—liver cancer	0.00265	0.00956	CcSEcCtD
Oseltamivir—Infestation NOS—Sorafenib—liver cancer	0.00265	0.00956	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.00263	0.00947	CcSEcCtD
Oseltamivir—Jaundice—Sorafenib—liver cancer	0.00259	0.00932	CcSEcCtD
Oseltamivir—Hepatobiliary disease—Sorafenib—liver cancer	0.00251	0.00904	CcSEcCtD
Oseltamivir—Epistaxis—Sorafenib—liver cancer	0.0025	0.00901	CcSEcCtD
Oseltamivir—Dermatitis atopic—Epirubicin—liver cancer	0.00237	0.00853	CcSEcCtD
Oseltamivir—Erythema multiforme—Sorafenib—liver cancer	0.00225	0.00811	CcSEcCtD
Oseltamivir—Otitis media—Epirubicin—liver cancer	0.00225	0.00811	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTA3—liver cancer	0.00223	0.0117	CbGpPWpGaD
Oseltamivir—Cardiac disorder—Sorafenib—liver cancer	0.00221	0.00796	CcSEcCtD
Oseltamivir—Dermatitis atopic—Doxorubicin—liver cancer	0.00219	0.00789	CcSEcCtD
Oseltamivir—Immune system disorder—Sorafenib—liver cancer	0.00215	0.00775	CcSEcCtD
Oseltamivir—Mediastinal disorder—Sorafenib—liver cancer	0.00215	0.00773	CcSEcCtD
Oseltamivir—Arrhythmia—Sorafenib—liver cancer	0.00213	0.00766	CcSEcCtD
Oseltamivir—Blood disorder—Epirubicin—liver cancer	0.0021	0.00756	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—DNAJB1—liver cancer	0.00209	0.011	CbGpPWpGaD
Oseltamivir—Mental disorder—Sorafenib—liver cancer	0.00209	0.00752	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00208	0.0109	CbGpPWpGaD
Oseltamivir—Otitis media—Doxorubicin—liver cancer	0.00208	0.0075	CcSEcCtD
Oseltamivir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00205	0.0107	CbGpPWpGaD
Oseltamivir—Delirium—Epirubicin—liver cancer	0.00204	0.00734	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTA4—liver cancer	0.00204	0.0107	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—GSTA2—liver cancer	0.00199	0.0104	CbGpPWpGaD
Oseltamivir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00195	0.0102	CbGpPWpGaD
Oseltamivir—Blood disorder—Doxorubicin—liver cancer	0.00194	0.00699	CcSEcCtD
Oseltamivir—Bone disorder—Epirubicin—liver cancer	0.00194	0.00699	CcSEcCtD
Oseltamivir—Anaemia—Sorafenib—liver cancer	0.00192	0.0069	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTA1—liver cancer	0.00192	0.01	CbGpPWpGaD
Oseltamivir—Herpes simplex—Epirubicin—liver cancer	0.0019	0.00685	CcSEcCtD
Oseltamivir—Angioedema—Sorafenib—liver cancer	0.00189	0.00682	CcSEcCtD
Oseltamivir—Delirium—Doxorubicin—liver cancer	0.00189	0.00679	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—EXOSC2—liver cancer	0.00185	0.0097	CbGpPWpGaD
Oseltamivir—Cough—Sorafenib—liver cancer	0.00181	0.00652	CcSEcCtD
Oseltamivir—Bone disorder—Doxorubicin—liver cancer	0.0018	0.00647	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00177	0.00927	CbGpPWpGaD
Oseltamivir—Myalgia—Sorafenib—liver cancer	0.00177	0.00636	CcSEcCtD
Oseltamivir—Arthralgia—Sorafenib—liver cancer	0.00177	0.00636	CcSEcCtD
Oseltamivir—Herpes simplex—Doxorubicin—liver cancer	0.00176	0.00634	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00175	0.00631	CcSEcCtD
Oseltamivir—Hepatocellular injury—Epirubicin—liver cancer	0.00175	0.00631	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00171	0.00894	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—YIF1A—liver cancer	0.00171	0.00893	CbGpPWpGaD
Oseltamivir—Influenza like illness—Epirubicin—liver cancer	0.0017	0.00613	CcSEcCtD
Oseltamivir—Anaphylactic shock—Sorafenib—liver cancer	0.00169	0.00609	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—NFE2L2—liver cancer	0.00169	0.00883	CbGpPWpGaD
Oseltamivir—Infection—Sorafenib—liver cancer	0.00168	0.00606	CcSEcCtD
Oseltamivir—Nervous system disorder—Sorafenib—liver cancer	0.00166	0.00598	CcSEcCtD
Oseltamivir—Thrombocytopenia—Sorafenib—liver cancer	0.00166	0.00597	CcSEcCtD
Oseltamivir—Skin disorder—Sorafenib—liver cancer	0.00164	0.00592	CcSEcCtD
Oseltamivir—Hepatocellular injury—Doxorubicin—liver cancer	0.00162	0.00584	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GPX3—liver cancer	0.00161	0.00843	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—TGFA—liver cancer	0.00161	0.00843	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—SERPINA1—liver cancer	0.00159	0.0083	CbGpPWpGaD
Oseltamivir—Influenza like illness—Doxorubicin—liver cancer	0.00157	0.00567	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00154	0.00555	CcSEcCtD
Oseltamivir—Lymphadenopathy—Epirubicin—liver cancer	0.00149	0.00537	CcSEcCtD
Oseltamivir—Dyspepsia—Sorafenib—liver cancer	0.00149	0.00537	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—MTHFR—liver cancer	0.00147	0.00768	CbGpPWpGaD
Oseltamivir—Diabetes mellitus—Epirubicin—liver cancer	0.00146	0.00527	CcSEcCtD
Oseltamivir—Gastrointestinal disorder—Sorafenib—liver cancer	0.00146	0.00526	CcSEcCtD
Oseltamivir—Fatigue—Sorafenib—liver cancer	0.00146	0.00525	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Epirubicin—liver cancer	0.00146	0.00524	CcSEcCtD
Oseltamivir—Pain—Sorafenib—liver cancer	0.00145	0.00521	CcSEcCtD
Oseltamivir—Eczema—Epirubicin—liver cancer	0.00142	0.0051	CcSEcCtD
Oseltamivir—Hepatic failure—Epirubicin—liver cancer	0.00142	0.0051	CcSEcCtD
Oseltamivir—Eye pain—Epirubicin—liver cancer	0.00141	0.00508	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—EXOSC2—liver cancer	0.00141	0.00735	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—SERPINA1—liver cancer	0.00139	0.00726	CbGpPWpGaD
Oseltamivir—Gastrointestinal pain—Sorafenib—liver cancer	0.00138	0.00498	CcSEcCtD
Oseltamivir—Lymphadenopathy—Doxorubicin—liver cancer	0.00138	0.00497	CcSEcCtD
Oseltamivir—Diabetes mellitus—Doxorubicin—liver cancer	0.00135	0.00488	CcSEcCtD
Oseltamivir—Hepatic function abnormal—Doxorubicin—liver cancer	0.00135	0.00485	CcSEcCtD
Oseltamivir—Urticaria—Sorafenib—liver cancer	0.00134	0.00484	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00134	0.00703	CbGpPWpGaD
Oseltamivir—Abdominal pain—Sorafenib—liver cancer	0.00134	0.00482	CcSEcCtD
Oseltamivir—Body temperature increased—Sorafenib—liver cancer	0.00134	0.00482	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINA1—liver cancer	0.00132	0.00691	CbGpPWpGaD
Oseltamivir—Anaphylactoid reaction—Epirubicin—liver cancer	0.00131	0.00474	CcSEcCtD
Oseltamivir—Eczema—Doxorubicin—liver cancer	0.00131	0.00472	CcSEcCtD
Oseltamivir—Hepatic failure—Doxorubicin—liver cancer	0.00131	0.00472	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00131	0.00683	CbGpPWpGaD
Oseltamivir—Eye pain—Doxorubicin—liver cancer	0.0013	0.0047	CcSEcCtD
Oseltamivir—NEU1—Metabolism—UGDH—liver cancer	0.0013	0.00681	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00129	0.00677	CbGpPWpGaD
Oseltamivir—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00127	0.00458	CcSEcCtD
Oseltamivir—Pain in extremity—Epirubicin—liver cancer	0.00127	0.00458	CcSEcCtD
Oseltamivir—Hypersensitivity—Sorafenib—liver cancer	0.00125	0.00449	CcSEcCtD
Oseltamivir—Face oedema—Epirubicin—liver cancer	0.00123	0.00442	CcSEcCtD
Oseltamivir—NEU1—Metabolism—EPT1—liver cancer	0.00122	0.00641	CbGpPWpGaD
Oseltamivir—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00122	0.00438	CcSEcCtD
Oseltamivir—Asthenia—Sorafenib—liver cancer	0.00121	0.00437	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTA3—liver cancer	0.0012	0.00629	CbGpPWpGaD
Oseltamivir—Pain in extremity—Doxorubicin—liver cancer	0.00118	0.00424	CcSEcCtD
Oseltamivir—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00118	0.00424	CcSEcCtD
Oseltamivir—Liver function test abnormal—Epirubicin—liver cancer	0.00117	0.00423	CcSEcCtD
Oseltamivir—Abdominal pain upper—Epirubicin—liver cancer	0.00116	0.00419	CcSEcCtD
Oseltamivir—NEU1—Metabolism—TAT—liver cancer	0.00116	0.00607	CbGpPWpGaD
Oseltamivir—Diarrhoea—Sorafenib—liver cancer	0.00116	0.00417	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.00115	0.00413	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00114	0.00597	CbGpPWpGaD
Oseltamivir—Nasopharyngitis—Epirubicin—liver cancer	0.00114	0.0041	CcSEcCtD
Oseltamivir—Face oedema—Doxorubicin—liver cancer	0.00114	0.00409	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GGT1—liver cancer	0.00113	0.00593	CbGpPWpGaD
Oseltamivir—Dizziness—Sorafenib—liver cancer	0.00112	0.00403	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTA4—liver cancer	0.0011	0.00576	CbGpPWpGaD
Oseltamivir—Influenza—Epirubicin—liver cancer	0.0011	0.00396	CcSEcCtD
Oseltamivir—Asthma—Epirubicin—liver cancer	0.0011	0.00396	CcSEcCtD
Oseltamivir—Liver function test abnormal—Doxorubicin—liver cancer	0.00109	0.00392	CcSEcCtD
Oseltamivir—Vomiting—Sorafenib—liver cancer	0.00108	0.00388	CcSEcCtD
Oseltamivir—Abdominal pain upper—Doxorubicin—liver cancer	0.00108	0.00387	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTA2—liver cancer	0.00107	0.00561	CbGpPWpGaD
Oseltamivir—Angina pectoris—Epirubicin—liver cancer	0.00107	0.00386	CcSEcCtD
Oseltamivir—Rash—Sorafenib—liver cancer	0.00107	0.00384	CcSEcCtD
Oseltamivir—Dermatitis—Sorafenib—liver cancer	0.00107	0.00384	CcSEcCtD
Oseltamivir—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.00106	0.00382	CcSEcCtD
Oseltamivir—Headache—Sorafenib—liver cancer	0.00106	0.00382	CcSEcCtD
Oseltamivir—Bronchitis—Epirubicin—liver cancer	0.00106	0.00381	CcSEcCtD
Oseltamivir—Nasopharyngitis—Doxorubicin—liver cancer	0.00105	0.00379	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—SERPINE1—liver cancer	0.00105	0.0055	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00105	0.00547	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—ATF3—liver cancer	0.00104	0.00545	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00104	0.00543	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00104	0.00543	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTA1—liver cancer	0.00103	0.00541	CbGpPWpGaD
Oseltamivir—CES1—Fluoropyrimidine Activity—TP53—liver cancer	0.00103	0.0054	CbGpPWpGaD
Oseltamivir—Upper respiratory tract infection—Epirubicin—liver cancer	0.00102	0.00368	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—GSTP1—liver cancer	0.00102	0.00533	CbGpPWpGaD
Oseltamivir—Asthma—Doxorubicin—liver cancer	0.00102	0.00367	CcSEcCtD
Oseltamivir—Influenza—Doxorubicin—liver cancer	0.00102	0.00367	CcSEcCtD
Oseltamivir—Nausea—Sorafenib—liver cancer	0.00101	0.00362	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—HMOX1—liver cancer	0.001	0.00525	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000997	0.00522	CbGpPWpGaD
Oseltamivir—NEU1—Post-translational protein modification—F2—liver cancer	0.000997	0.00521	CbGpPWpGaD
Oseltamivir—Angina pectoris—Doxorubicin—liver cancer	0.000991	0.00357	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00099	0.00518	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—UGDH—liver cancer	0.000987	0.00516	CbGpPWpGaD
Oseltamivir—Pneumonia—Epirubicin—liver cancer	0.000986	0.00355	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—CDKN2A—liver cancer	0.000982	0.00514	CbGpPWpGaD
Oseltamivir—Infestation—Epirubicin—liver cancer	0.00098	0.00353	CcSEcCtD
Oseltamivir—Infestation NOS—Epirubicin—liver cancer	0.00098	0.00353	CcSEcCtD
Oseltamivir—Bronchitis—Doxorubicin—liver cancer	0.000979	0.00352	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000972	0.0035	CcSEcCtD
Oseltamivir—Jaundice—Epirubicin—liver cancer	0.000956	0.00344	CcSEcCtD
Oseltamivir—Conjunctivitis—Epirubicin—liver cancer	0.000953	0.00343	CcSEcCtD
Oseltamivir—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000946	0.00341	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—HGF—liver cancer	0.000935	0.00489	CbGpPWpGaD
Oseltamivir—CES1—NRF2 pathway—GSTM1—liver cancer	0.000935	0.00489	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00093	0.00487	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—EPT1—liver cancer	0.000928	0.00486	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Epirubicin—liver cancer	0.000927	0.00334	CcSEcCtD
Oseltamivir—Epistaxis—Epirubicin—liver cancer	0.000925	0.00333	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000923	0.00483	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000923	0.00483	CbGpPWpGaD
Oseltamivir—Sinusitis—Epirubicin—liver cancer	0.00092	0.00331	CcSEcCtD
Oseltamivir—Pneumonia—Doxorubicin—liver cancer	0.000912	0.00329	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—NFE2L2—liver cancer	0.000912	0.00477	CbGpPWpGaD
Oseltamivir—Infestation NOS—Doxorubicin—liver cancer	0.000907	0.00327	CcSEcCtD
Oseltamivir—Infestation—Doxorubicin—liver cancer	0.000907	0.00327	CcSEcCtD
Oseltamivir—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000899	0.00324	CcSEcCtD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.000887	0.00464	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—MYO5B—liver cancer	0.000885	0.00463	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.000885	0.00463	CbGpPWpGaD
Oseltamivir—Jaundice—Doxorubicin—liver cancer	0.000884	0.00319	CcSEcCtD
Oseltamivir—Conjunctivitis—Doxorubicin—liver cancer	0.000882	0.00318	CcSEcCtD
Oseltamivir—Hepatitis—Epirubicin—liver cancer	0.00088	0.00317	CcSEcCtD
Oseltamivir—NEU2—Metabolism—TAT—liver cancer	0.00088	0.0046	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GPX3—liver cancer	0.00087	0.00455	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFA—liver cancer	0.00087	0.00455	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—CDKN1B—liver cancer	0.00087	0.00455	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—IGF2—liver cancer	0.000866	0.00453	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000865	0.00453	CbGpPWpGaD
Oseltamivir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000858	0.00309	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—SERPINA1—liver cancer	0.000857	0.00448	CbGpPWpGaD
Oseltamivir—Epistaxis—Doxorubicin—liver cancer	0.000856	0.00308	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000855	0.00447	CbGpPWpGaD
Oseltamivir—Sinusitis—Doxorubicin—liver cancer	0.000851	0.00307	CcSEcCtD
Oseltamivir—Visual impairment—Epirubicin—liver cancer	0.000848	0.00306	CcSEcCtD
Oseltamivir—Erythema multiforme—Epirubicin—liver cancer	0.000832	0.003	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—IGF2—liver cancer	0.000825	0.00431	CbGpPWpGaD
Oseltamivir—Eye disorder—Epirubicin—liver cancer	0.000823	0.00296	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—HGF—liver cancer	0.000817	0.00428	CbGpPWpGaD
Oseltamivir—Cardiac disorder—Epirubicin—liver cancer	0.000817	0.00294	CcSEcCtD
Oseltamivir—Hepatitis—Doxorubicin—liver cancer	0.000814	0.00293	CcSEcCtD
Oseltamivir—CES1—E2F transcription factor network—CDKN1A—liver cancer	0.000803	0.0042	CbGpPWpGaD
Oseltamivir—Immune system disorder—Epirubicin—liver cancer	0.000795	0.00286	CcSEcCtD
Oseltamivir—Mediastinal disorder—Epirubicin—liver cancer	0.000793	0.00286	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—ATF3—liver cancer	0.000789	0.00413	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GLUL—liver cancer	0.000789	0.00413	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CPT1B—liver cancer	0.000789	0.00413	CbGpPWpGaD
Oseltamivir—Arrhythmia—Epirubicin—liver cancer	0.000786	0.00283	CcSEcCtD
Oseltamivir—Visual impairment—Doxorubicin—liver cancer	0.000785	0.00283	CcSEcCtD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—liver cancer	0.000779	0.00407	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HBE1—liver cancer	0.000775	0.00405	CbGpPWpGaD
Oseltamivir—Mental disorder—Epirubicin—liver cancer	0.000771	0.00278	CcSEcCtD
Oseltamivir—Erythema multiforme—Doxorubicin—liver cancer	0.00077	0.00277	CcSEcCtD
Oseltamivir—Eye disorder—Doxorubicin—liver cancer	0.000761	0.00274	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NR1H4—liver cancer	0.000761	0.00398	CbGpPWpGaD
Oseltamivir—Cardiac disorder—Doxorubicin—liver cancer	0.000756	0.00272	CcSEcCtD
Oseltamivir—NEU2—Post-translational protein modification—F2—liver cancer	0.000755	0.00395	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTA3—liver cancer	0.000748	0.00391	CbGpPWpGaD
Oseltamivir—Back pain—Epirubicin—liver cancer	0.000741	0.00267	CcSEcCtD
Oseltamivir—Immune system disorder—Doxorubicin—liver cancer	0.000736	0.00265	CcSEcCtD
Oseltamivir—Mediastinal disorder—Doxorubicin—liver cancer	0.000734	0.00264	CcSEcCtD
Oseltamivir—Arrhythmia—Doxorubicin—liver cancer	0.000728	0.00262	CcSEcCtD
Oseltamivir—Mental disorder—Doxorubicin—liver cancer	0.000713	0.00257	CcSEcCtD
Oseltamivir—Anaemia—Epirubicin—liver cancer	0.000708	0.00255	CcSEcCtD
Oseltamivir—Agitation—Epirubicin—liver cancer	0.000704	0.00254	CcSEcCtD
Oseltamivir—Vertigo—Epirubicin—liver cancer	0.000688	0.00248	CcSEcCtD
Oseltamivir—Back pain—Doxorubicin—liver cancer	0.000686	0.00247	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTA4—liver cancer	0.000684	0.00358	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000669	0.0035	CbGpPWpGaD
Oseltamivir—Cough—Epirubicin—liver cancer	0.000669	0.00241	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GSTA2—liver cancer	0.000667	0.00349	CbGpPWpGaD
Oseltamivir—CES1—E2F transcription factor network—MYC—liver cancer	0.000665	0.00348	CbGpPWpGaD
Oseltamivir—Convulsion—Epirubicin—liver cancer	0.000664	0.00239	CcSEcCtD
Oseltamivir—Anaemia—Doxorubicin—liver cancer	0.000655	0.00236	CcSEcCtD
Oseltamivir—Arthralgia—Epirubicin—liver cancer	0.000652	0.00235	CcSEcCtD
Oseltamivir—Myalgia—Epirubicin—liver cancer	0.000652	0.00235	CcSEcCtD
Oseltamivir—Agitation—Doxorubicin—liver cancer	0.000652	0.00235	CcSEcCtD
Oseltamivir—Anxiety—Epirubicin—liver cancer	0.00065	0.00234	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000648	0.00233	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000648	0.00339	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—IGF2—liver cancer	0.000645	0.00338	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTA1—liver cancer	0.000643	0.00337	CbGpPWpGaD
Oseltamivir—Vertigo—Doxorubicin—liver cancer	0.000637	0.00229	CcSEcCtD
Oseltamivir—NEU1—Metabolism—NAT2—liver cancer	0.000636	0.00333	CbGpPWpGaD
Oseltamivir—Confusional state—Epirubicin—liver cancer	0.000631	0.00227	CcSEcCtD
Oseltamivir—Anaphylactic shock—Epirubicin—liver cancer	0.000625	0.00225	CcSEcCtD
Oseltamivir—Infection—Epirubicin—liver cancer	0.000621	0.00224	CcSEcCtD
Oseltamivir—Cough—Doxorubicin—liver cancer	0.000619	0.00223	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SERPINA1—liver cancer	0.000615	0.00322	CbGpPWpGaD
Oseltamivir—Convulsion—Doxorubicin—liver cancer	0.000614	0.00221	CcSEcCtD
Oseltamivir—Nervous system disorder—Epirubicin—liver cancer	0.000613	0.00221	CcSEcCtD
Oseltamivir—Thrombocytopenia—Epirubicin—liver cancer	0.000612	0.00221	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GGT1—liver cancer	0.000612	0.0032	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000612	0.0032	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ALDOB—liver cancer	0.00061	0.00319	CbGpPWpGaD
Oseltamivir—Skin disorder—Epirubicin—liver cancer	0.000607	0.00219	CcSEcCtD
Oseltamivir—Myalgia—Doxorubicin—liver cancer	0.000604	0.00217	CcSEcCtD
Oseltamivir—Arthralgia—Doxorubicin—liver cancer	0.000604	0.00217	CcSEcCtD
Oseltamivir—Anxiety—Doxorubicin—liver cancer	0.000601	0.00217	CcSEcCtD
Oseltamivir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000599	0.00216	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GLUL—liver cancer	0.000598	0.00313	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CPT1B—liver cancer	0.000598	0.00313	CbGpPWpGaD
Oseltamivir—Confusional state—Doxorubicin—liver cancer	0.000583	0.0021	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CRABP1—liver cancer	0.000582	0.00304	CbGpPWpGaD
Oseltamivir—Anaphylactic shock—Doxorubicin—liver cancer	0.000579	0.00208	CcSEcCtD
Oseltamivir—NEU2—Metabolism—NR1H4—liver cancer	0.000577	0.00302	CbGpPWpGaD
Oseltamivir—Infection—Doxorubicin—liver cancer	0.000575	0.00207	CcSEcCtD
Oseltamivir—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00057	0.00205	CcSEcCtD
Oseltamivir—Nervous system disorder—Doxorubicin—liver cancer	0.000567	0.00204	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTA3—liver cancer	0.000567	0.00297	CbGpPWpGaD
Oseltamivir—Thrombocytopenia—Doxorubicin—liver cancer	0.000567	0.00204	CcSEcCtD
Oseltamivir—Insomnia—Epirubicin—liver cancer	0.000566	0.00204	CcSEcCtD
Oseltamivir—Skin disorder—Doxorubicin—liver cancer	0.000562	0.00202	CcSEcCtD
Oseltamivir—ABCC4—Fluoropyrimidine Activity—TP53—liver cancer	0.000557	0.00291	CbGpPWpGaD
Oseltamivir—Dyspepsia—Epirubicin—liver cancer	0.00055	0.00198	CcSEcCtD
Oseltamivir—ABCC4—NRF2 pathway—GSTP1—liver cancer	0.00055	0.00288	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—HMOX1—liver cancer	0.000542	0.00284	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Epirubicin—liver cancer	0.00054	0.00194	CcSEcCtD
Oseltamivir—Fatigue—Epirubicin—liver cancer	0.000539	0.00194	CcSEcCtD
Oseltamivir—Pain—Epirubicin—liver cancer	0.000535	0.00193	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000531	0.00278	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—SERPINE1—liver cancer	0.000528	0.00276	CbGpPWpGaD
Oseltamivir—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000527	0.0019	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—ALB—liver cancer	0.000527	0.00276	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000524	0.00274	CbGpPWpGaD
Oseltamivir—Insomnia—Doxorubicin—liver cancer	0.000523	0.00189	CcSEcCtD
Oseltamivir—NEU2—Metabolism—GSTA4—liver cancer	0.000519	0.00271	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Epirubicin—liver cancer	0.000515	0.00186	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Epirubicin—liver cancer	0.000511	0.00184	CcSEcCtD
Oseltamivir—Dyspepsia—Doxorubicin—liver cancer	0.000509	0.00183	CcSEcCtD
Oseltamivir—NEU1—Metabolism—HPGDS—liver cancer	0.000509	0.00266	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000507	0.00265	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000507	0.00265	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000506	0.00264	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTA2—liver cancer	0.000505	0.00264	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—GSTM1—liver cancer	0.000505	0.00264	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—HGF—liver cancer	0.000505	0.00264	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—liver cancer	0.000503	0.00263	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—liver cancer	0.000502	0.00263	CbGpPWpGaD
Oseltamivir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.0005	0.0018	CcSEcCtD
Oseltamivir—Fatigue—Doxorubicin—liver cancer	0.000499	0.0018	CcSEcCtD
Oseltamivir—Urticaria—Epirubicin—liver cancer	0.000497	0.00179	CcSEcCtD
Oseltamivir—Pain—Doxorubicin—liver cancer	0.000495	0.00178	CcSEcCtD
Oseltamivir—Body temperature increased—Epirubicin—liver cancer	0.000494	0.00178	CcSEcCtD
Oseltamivir—Abdominal pain—Epirubicin—liver cancer	0.000494	0.00178	CcSEcCtD
Oseltamivir—NEU2—Metabolism of proteins—IGF2—liver cancer	0.000489	0.00256	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTA1—liver cancer	0.000488	0.00255	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000486	0.00254	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000486	0.00254	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—NAT2—liver cancer	0.000482	0.00252	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ANXA2—liver cancer	0.000479	0.0025	CbGpPWpGaD
Oseltamivir—Feeling abnormal—Doxorubicin—liver cancer	0.000477	0.00172	CcSEcCtD
Oseltamivir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000473	0.0017	CcSEcCtD
Oseltamivir—NEU1—Metabolism of proteins—F2—liver cancer	0.000473	0.00247	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000473	0.00247	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000464	0.00243	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALDOB—liver cancer	0.000462	0.00242	CbGpPWpGaD
Oseltamivir—Hypersensitivity—Epirubicin—liver cancer	0.000461	0.00166	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.00046	0.00241	CbGpPWpGaD
Oseltamivir—Urticaria—Doxorubicin—liver cancer	0.00046	0.00166	CcSEcCtD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00046	0.0024	CbGpPWpGaD
Oseltamivir—Body temperature increased—Doxorubicin—liver cancer	0.000457	0.00165	CcSEcCtD
Oseltamivir—Abdominal pain—Doxorubicin—liver cancer	0.000457	0.00165	CcSEcCtD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000455	0.00238	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PSMD10—liver cancer	0.000453	0.00237	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PSMA4—liver cancer	0.000453	0.00237	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000453	0.00237	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000451	0.00236	CbGpPWpGaD
Oseltamivir—Asthenia—Epirubicin—liver cancer	0.000449	0.00162	CcSEcCtD
Oseltamivir—NEU1—Metabolism—GOT2—liver cancer	0.000441	0.00231	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CRABP1—liver cancer	0.000441	0.00231	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000432	0.00226	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000432	0.00226	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000432	0.00226	CbGpPWpGaD
Oseltamivir—Diarrhoea—Epirubicin—liver cancer	0.000428	0.00154	CcSEcCtD
Oseltamivir—Hypersensitivity—Doxorubicin—liver cancer	0.000426	0.00154	CcSEcCtD
Oseltamivir—Asthenia—Doxorubicin—liver cancer	0.000415	0.0015	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYP2E1—liver cancer	0.000415	0.00217	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000414	0.00217	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000414	0.00217	CbGpPWpGaD
Oseltamivir—Dizziness—Epirubicin—liver cancer	0.000414	0.00149	CcSEcCtD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000409	0.00214	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.000405	0.00212	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000401	0.0021	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—MMP2—liver cancer	0.000401	0.0021	CbGpPWpGaD
Oseltamivir—Vomiting—Epirubicin—liver cancer	0.000398	0.00143	CcSEcCtD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000397	0.00208	CbGpPWpGaD
Oseltamivir—Diarrhoea—Doxorubicin—liver cancer	0.000396	0.00143	CcSEcCtD
Oseltamivir—Rash—Epirubicin—liver cancer	0.000394	0.00142	CcSEcCtD
Oseltamivir—Dermatitis—Epirubicin—liver cancer	0.000394	0.00142	CcSEcCtD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000392	0.00205	CbGpPWpGaD
Oseltamivir—Headache—Epirubicin—liver cancer	0.000392	0.00141	CcSEcCtD
Oseltamivir—NEU1—Metabolism—CYCS—liver cancer	0.000388	0.00203	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HPGDS—liver cancer	0.000385	0.00202	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.000384	0.00201	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000383	0.002	CbGpPWpGaD
Oseltamivir—Dizziness—Doxorubicin—liver cancer	0.000383	0.00138	CcSEcCtD
Oseltamivir—CES1—NRF2 pathway—TGFB1—liver cancer	0.000381	0.00199	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GGT1—liver cancer	0.000381	0.00199	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GOT1—liver cancer	0.000381	0.00199	CbGpPWpGaD
Oseltamivir—Nausea—Epirubicin—liver cancer	0.000371	0.00134	CcSEcCtD
Oseltamivir—Vomiting—Doxorubicin—liver cancer	0.000368	0.00133	CcSEcCtD
Oseltamivir—Rash—Doxorubicin—liver cancer	0.000365	0.00131	CcSEcCtD
Oseltamivir—Dermatitis—Doxorubicin—liver cancer	0.000364	0.00131	CcSEcCtD
Oseltamivir—ABCC4—Platelet degranulation—VEGFA—liver cancer	0.000363	0.0019	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—HGF—liver cancer	0.000363	0.0019	CbGpPWpGaD
Oseltamivir—Headache—Doxorubicin—liver cancer	0.000362	0.00131	CcSEcCtD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000359	0.00188	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—F2—liver cancer	0.000358	0.00188	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000349	0.00183	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	0.000346	0.00181	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000344	0.0018	CbGpPWpGaD
Oseltamivir—Nausea—Doxorubicin—liver cancer	0.000344	0.00124	CcSEcCtD
Oseltamivir—NEU2—Metabolism—PSMA4—liver cancer	0.000343	0.0018	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PSMD10—liver cancer	0.000343	0.0018	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTP1—liver cancer	0.000342	0.00179	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—HMOX1—liver cancer	0.000337	0.00176	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GOT2—liver cancer	0.000334	0.00175	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet degranulation—TGFB1—liver cancer	0.000333	0.00174	CbGpPWpGaD
Oseltamivir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	0.000317	0.00166	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SERPINA1—liver cancer	0.000317	0.00166	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—GSTM1—liver cancer	0.000314	0.00164	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP2E1—liver cancer	0.000314	0.00164	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of proteins—CTNNB1—liver cancer	0.000307	0.00161	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000304	0.00159	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—MMP2—liver cancer	0.000304	0.00159	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—CYP1A1—liver cancer	0.000298	0.00156	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYCS—liver cancer	0.000294	0.00154	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.00029	0.00152	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GGT1—liver cancer	0.000288	0.00151	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GOT1—liver cancer	0.000288	0.00151	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—F2—liver cancer	0.000281	0.00147	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—MTHFR—liver cancer	0.000278	0.00145	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PPARA—liver cancer	0.000272	0.00143	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	0.000269	0.00141	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—CTNNB1—liver cancer	0.000267	0.00139	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTP1—liver cancer	0.000259	0.00136	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—HMOX1—liver cancer	0.000256	0.00134	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000245	0.00128	CbGpPWpGaD
Oseltamivir—SLC15A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000241	0.00126	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—GSTM1—liver cancer	0.000238	0.00125	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	0.000237	0.00124	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IFNA1—liver cancer	0.000236	0.00124	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000234	0.00123	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	0.000234	0.00122	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—ALB—liver cancer	0.000234	0.00122	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CG—liver cancer	0.000233	0.00122	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of proteins—CTNNB1—liver cancer	0.000233	0.00122	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—CYP1A1—liver cancer	0.000226	0.00118	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PPARG—liver cancer	0.000225	0.00118	CbGpPWpGaD
Oseltamivir—ABCC4—Ectoderm Differentiation—MYC—liver cancer	0.000216	0.00113	CbGpPWpGaD
Oseltamivir—SLC22A8—SLC-mediated transmembrane transport—ALB—liver cancer	0.000214	0.00112	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—RAF1—liver cancer	0.000211	0.00111	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—MTHFR—liver cancer	0.00021	0.0011	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PRKCE—liver cancer	0.000209	0.00109	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—CYCS—liver cancer	0.000208	0.00109	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PPARA—liver cancer	0.000206	0.00108	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	0.000206	0.00108	CbGpPWpGaD
Oseltamivir—ABCC4—NRF2 pathway—TGFB1—liver cancer	0.000206	0.00108	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CD—liver cancer	0.000205	0.00107	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000204	0.00107	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—ALB—liver cancer	0.000202	0.00106	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—CYCS—liver cancer	0.0002	0.00104	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ABL1—liver cancer	0.000199	0.00104	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IGF2—liver cancer	0.000198	0.00104	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—IL2—liver cancer	0.000189	0.000991	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HGF—liver cancer	0.000187	0.000978	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.000185	0.00097	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—CSF2—liver cancer	0.000185	0.000967	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000181	0.000947	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CB—liver cancer	0.000179	0.000935	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CG—liver cancer	0.000177	0.000925	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000174	0.000908	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PPARG—liver cancer	0.000171	0.000893	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000165	0.000861	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—liver cancer	0.000161	0.000842	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CD—liver cancer	0.000155	0.000813	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—ALB—liver cancer	0.000153	0.000803	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—MAPK14—liver cancer	0.00015	0.000783	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—TGFB1—liver cancer	0.000148	0.000773	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—PPARA—liver cancer	0.000146	0.000765	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—F2—liver cancer	0.000145	0.000759	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—PPARA—liver cancer	0.00014	0.000734	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CG—liver cancer	0.000139	0.000726	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CB—liver cancer	0.000135	0.000709	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	0.000126	0.000658	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000122	0.00064	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CD—liver cancer	0.000122	0.000638	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—SERPINE1—liver cancer	0.000121	0.000631	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—ALB—liver cancer	0.00012	0.00063	CbGpPWpGaD
Oseltamivir—SLC15A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000111	0.000578	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—PIK3CA—liver cancer	0.000109	0.00057	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—RAF1—liver cancer	0.000109	0.00057	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—ALB—liver cancer	0.000109	0.000569	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CB—liver cancer	0.000106	0.000556	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—ALB—liver cancer	0.000104	0.000545	CbGpPWpGaD
Oseltamivir—ABCC4—Platelet activation, signaling and aggregation—AKT1—liver cancer	0.000103	0.000537	CbGpPWpGaD
Oseltamivir—SLC22A8—Transmembrane transport of small molecules—RAF1—liver cancer	9.83e-05	0.000514	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—IL2—liver cancer	9.77e-05	0.000511	CbGpPWpGaD
Oseltamivir—ABCC4—Transmembrane transport of small molecules—RAF1—liver cancer	9.43e-05	0.000493	CbGpPWpGaD
Oseltamivir—NEU1—Metabolism—AKT1—liver cancer	8.9e-05	0.000466	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—VEGFA—liver cancer	8.3e-05	0.000434	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—PIK3CA—liver cancer	8.26e-05	0.000432	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TGFB1—liver cancer	7.62e-05	0.000399	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—KRAS—liver cancer	7.06e-05	0.000369	CbGpPWpGaD
Oseltamivir—NEU2—Metabolism—AKT1—liver cancer	6.75e-05	0.000353	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—PIK3CA—liver cancer	6.48e-05	0.000339	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—TP53—liver cancer	6.27e-05	0.000328	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—HRAS—liver cancer	6e-05	0.000314	CbGpPWpGaD
Oseltamivir—ABCC4—Hemostasis—AKT1—liver cancer	5.3e-05	0.000277	CbGpPWpGaD
